AdaptHealth (AHCO) Cash from Investing Activities (2018 - 2026)

AdaptHealth has reported Cash from Investing Activities for 9 years, with the latest figure at -$202.7 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities fell 2210.72% year-over-year to -$202.7 million in Q2 2026; TTM through Jun 2026 was -$624.4 million, a 174.94% decrease from a year earlier, with the FY2025 full-year figure at -$303.2 million, up 2.28% from the prior year.
• Cash from Investing Activities was -$202.7 million for Q2 2026 at AdaptHealth, up from -$204.5 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $9.6 million in Q2 2025, with the low at -$204.5 million in Q1 2026.
• Average Cash from Investing Activities over 5 years is -$99.4 million, with a median of -$90.2 million recorded in 2022.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities jumped 111.82% in 2025, then sank 2210.72% in 2026.
• Over 5 years, Cash from Investing Activities stood at -$145.8 million in 2022, then jumped by 37.98% to -$90.4 million in 2023, then rose by 3.92% to -$86.9 million in 2024, then slumped by 43.28% to -$124.5 million in 2025, then sank by 62.86% to -$202.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$202.7 million (Q2 2026), -$204.5 million (Q1 2026), and -$124.5 million (Q4 2025), per Business Quant data.